Effects of intracoronary injection of ergonovine on angiographic normal coronary arteries: study of 108 consecutive patients. 1989

J A Fournier, and J A Cortacero, and A Turá, and C Hernández-Aparicio, and C Granado, and J Vallejo
Virgen Del Rocio University Hospital, Service of Cardiology, Seville, Spain.

To assess the local and systemic intracoronary (IC) ergonovine maleate (EM), single or repeated 25 micrograms bolus injections were administered to 108 consecutive patients with chest pain and normal coronary arteriograms. Coronary artery spasm (CAS) was induced in 17 (15.7%) patients. None of these patients developed ST-segment depression, and ST-segment elevation appeared in only 6 (35.3%). In 59 of the 91 patients without CAS, both the IC and the intravenous (IV) EM arteriographic and hemodynamic effects were compared. The mean diameter of the vessels was reduced by 15% (p less than 0.001) after two single 25 micrograms ICEM injections. Only insignificant changes were induced in the heart rate (baseline 80 +/- 15; after ICEM 79 +/- 15 beats/min; p = NS) and systolic aortic pressure (baseline 147 +/- 27; after ICEM 149 +/- 28 mmHG; p = NS). Following 350 micrograms of cumulative IVEM, the mean coronary diameter decreased by 20% (p less than 0.01 vs. ICEM dose) and the heart rate diminished slightly (76 +/- 12 beats/min, p less than 0.01). However, the systolic aortic pressures did increase by 16% (171 +/- 28 mmHg; p less than 0.001). No major complications were observed. Thus, to induce CAS the IC delivery route appears to be safe, allows for more accurate titration, and adverse systemic effects, such as hypertension, are avoided.

UI MeSH Term Description Entries
D007269 Injections, Intra-Arterial Delivery of drugs into an artery. Injections, Intraarterial,Intra-Arterial Injections,Intraarterial Injections,Injection, Intra-Arterial,Injection, Intraarterial,Injections, Intra Arterial,Intra Arterial Injections,Intra-Arterial Injection,Intraarterial Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003329 Coronary Vasospasm Spasm of the large- or medium-sized coronary arteries. Coronary Artery Spasm,Coronary Artery Vasospasm,Artery Spasm, Coronary,Artery Vasospasm, Coronary,Coronary Artery Spasms,Coronary Artery Vasospasms,Coronary Vasospasms,Spasm, Coronary Artery,Vasospasm, Coronary,Vasospasm, Coronary Artery
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D004874 Ergonovine An ergot alkaloid (ERGOT ALKALOIDS) with uterine and VASCULAR SMOOTH MUSCLE contractile properties. Ergometrine,Ergonovine Maleate,Ergobasin,Ergometrin,Ergometrine Maleate,Ergotrate
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J A Fournier, and J A Cortacero, and A Turá, and C Hernández-Aparicio, and C Granado, and J Vallejo
January 2019, Cardiology journal,
J A Fournier, and J A Cortacero, and A Turá, and C Hernández-Aparicio, and C Granado, and J Vallejo
March 1985, Texas Heart Institute journal,
J A Fournier, and J A Cortacero, and A Turá, and C Hernández-Aparicio, and C Granado, and J Vallejo
March 1992, American heart journal,
J A Fournier, and J A Cortacero, and A Turá, and C Hernández-Aparicio, and C Granado, and J Vallejo
August 1984, British heart journal,
J A Fournier, and J A Cortacero, and A Turá, and C Hernández-Aparicio, and C Granado, and J Vallejo
December 1990, The American journal of cardiology,
J A Fournier, and J A Cortacero, and A Turá, and C Hernández-Aparicio, and C Granado, and J Vallejo
September 2002, The Canadian journal of cardiology,
J A Fournier, and J A Cortacero, and A Turá, and C Hernández-Aparicio, and C Granado, and J Vallejo
June 2022, Heart and vessels,
J A Fournier, and J A Cortacero, and A Turá, and C Hernández-Aparicio, and C Granado, and J Vallejo
April 2024, Cardiovascular revascularization medicine : including molecular interventions,
J A Fournier, and J A Cortacero, and A Turá, and C Hernández-Aparicio, and C Granado, and J Vallejo
December 1989, International journal of cardiology,
Copied contents to your clipboard!